Cargando…

Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial

Detalles Bibliográficos
Autores principales: Tebas, P, Ramirez, L, Morrow, MP, Yan, J, Shah, D, Lee, J, Weiner, DB, Boyer, J, Bagarazzi, M, Sardesai, NY
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441269/
http://dx.doi.org/10.1186/1742-4690-9-S2-P276
_version_ 1782243251313442816
author Tebas, P
Ramirez, L
Morrow, MP
Yan, J
Shah, D
Lee, J
Weiner, DB
Boyer, J
Bagarazzi, M
Sardesai, NY
author_facet Tebas, P
Ramirez, L
Morrow, MP
Yan, J
Shah, D
Lee, J
Weiner, DB
Boyer, J
Bagarazzi, M
Sardesai, NY
author_sort Tebas, P
collection PubMed
description
format Online
Article
Text
id pubmed-3441269
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34412692012-09-18 Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial Tebas, P Ramirez, L Morrow, MP Yan, J Shah, D Lee, J Weiner, DB Boyer, J Bagarazzi, M Sardesai, NY Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441269/ http://dx.doi.org/10.1186/1742-4690-9-S2-P276 Text en Copyright ©2012 Tebas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Tebas, P
Ramirez, L
Morrow, MP
Yan, J
Shah, D
Lee, J
Weiner, DB
Boyer, J
Bagarazzi, M
Sardesai, NY
Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
title Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
title_full Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
title_fullStr Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
title_full_unstemmed Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
title_short Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial
title_sort potent cellular immune responses after therapeutic immunization of hiv-positive patients with the pennvax®-b dna vaccine in a phase i trial
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441269/
http://dx.doi.org/10.1186/1742-4690-9-S2-P276
work_keys_str_mv AT tebasp potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT ramirezl potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT morrowmp potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT yanj potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT shahd potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT leej potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT weinerdb potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT boyerj potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT bagarazzim potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial
AT sardesainy potentcellularimmuneresponsesaftertherapeuticimmunizationofhivpositivepatientswiththepennvaxbdnavaccineinaphaseitrial